Skip to Content

Our Mission

Apply acoustic cell processing to industrialize cell therapy manufacturing thus helping to reduce cost and improve patient accessibility

Our Vision

A modernized cell therapy process with closed, automated and integrated systems for each step based on FloDesign Sonics’ acoustic engine in both off the shelf formats as well as bespoke solutions

2012
NSF Phase I SBIR AWARD
2013
Series A Funding

BioPharm Separations Development Program

NSF Phase II SBIR AWARD
2014
Multiple Biotech Co-Development Agreements Signed

NIH Phase I SBIR AWARD
2015
Pall Corp License Agreement

Cell and Gene Therapy Development Program
2016
NSF Phase IIB AWARD

PALL Launches Acoustic Based CadenceTM System
2017
Expanded Development Program to Explore Concentrate / Wash, Cell Selection and Cell Retention Applications
2018
Launched Beta Demonstration System

Cognate BioServices Collaboration

Significant Investment in FDS Team. Hiring Key Industry Experts

Our Team

Board Members

Put an Acoustic Engine in Your Process